Drugs / OM-85 BV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00733226 Comparator | Aug 2007 → Sep 2008 | asthma | Kecioren Education and Training Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OM-85 BV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00733226 ↗ |
| Modality | Other / unclassified | “OM-85 BV is an bacteria lysate” NCT00733226 ↗ |
| Route | Oral | “The children received one capsule per oral, OM-85 BV (3.5 mg) per day” NCT00733226 ↗ |